Company Overview of Philogen S.p.A.
Philogen S.p.A., a biotechnology company, is engaged in the discovery and development of biopharmaceutical products for the treatment of certain diseases that are characterized by angiogenesis, the proliferation of newly formed blood vessels. The company focuses on delivering bioactive agents, such as cytokines, radionuclides, or drugs to the site of disease using antibodies and ligands that specifically target stromal antigens. It develops anti-cancer antibody derivatives and antibody-derivatives for the treatment of rheumatoid arthritis. Its products include DARLEUKIN (L19-IL2), Teleukin, and Fibromun (L19-TNF) that are human vascular targeting immunocytokine. The company also develops L19...
Via Bellaria, 35
Sovicille, SI 53018
Founded in 1996
Key Executives for Philogen S.p.A.
Vice President and Director
Compensation as of Fiscal Year 2014.
Philogen S.p.A. Key Developments
Philogen S.p.A. Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-11-2013
Feb 7 13
Philogen S.p.A. Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-11-2013 . Venue: Centre Covencions International Barcelona, Plaça de Willy Brandt, 11-14, 08019 Barcelona, Spain.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries